These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15913700)

  • 21. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
    Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
    J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: implications for membrane fusion.
    Liu J; Shu W; Fagan MB; Nunberg JH; Lu M
    Biochemistry; 2001 Mar; 40(9):2797-807. PubMed ID: 11258890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide and non-peptide HIV fusion inhibitors.
    Jiang S; Zhao Q; Debnath AK
    Curr Pharm Des; 2002; 8(8):563-80. PubMed ID: 11945159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.
    Cleveland SM; McLain L; Cheung L; Jones TD; Hollier M; Dimmock NJ
    J Gen Virol; 2003 Mar; 84(Pt 3):591-602. PubMed ID: 12604810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid-state nuclear magnetic resonance (NMR) spectroscopy of human immunodeficiency virus gp41 protein that includes the fusion peptide: NMR detection of recombinant Fgp41 in inclusion bodies in whole bacterial cells and structural characterization of purified and membrane-associated Fgp41.
    Vogel EP; Curtis-Fisk J; Young KM; Weliky DP
    Biochemistry; 2011 Nov; 50(46):10013-26. PubMed ID: 21985645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission.
    Ramakrishnan R; Mehta R; Sundaravaradan V; Davis T; Ahmad N
    Retrovirology; 2006 Jul; 3():42. PubMed ID: 16820061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
    J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41.
    Kalia V; Sarkar S; Gupta P; Montelaro RC
    J Virol; 2005 Feb; 79(4):2097-107. PubMed ID: 15681412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein.
    Miyauchi K; Curran AR; Long Y; Kondo N; Iwamoto A; Engelman DM; Matsuda Z
    Retrovirology; 2010 Nov; 7():95. PubMed ID: 21073746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants.
    Holguín A; De Arellano ER; Soriano V
    AIDS Res Hum Retroviruses; 2007 Sep; 23(9):1067-74. PubMed ID: 17919099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
    Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
    Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide.
    Weissenhorn W; Wharton SA; Calder LJ; Earl PL; Moss B; Aliprandis E; Skehel JJ; Wiley DC
    EMBO J; 1996 Apr; 15(7):1507-14. PubMed ID: 8612573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data.
    Boutonnet N; Janssens W; Boutton C; Verschelde JL; Heyndrickx L; Beirnaert E; van der Groen G; Lasters I
    J Virol; 2002 Aug; 76(15):7595-606. PubMed ID: 12097573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity.
    Piller SC; Dubay JW; Derdeyn CA; Hunter E
    J Virol; 2000 Dec; 74(24):11717-23. PubMed ID: 11090171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
    Medinas RJ; Lambert DM; Tompkins WA
    J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of hydrophobic residues in the central ectodomain of gp41 in maintaining the association between human immunodeficiency virus type 1 envelope glycoprotein subunits gp120 and gp41.
    York J; Nunberg JH
    J Virol; 2004 May; 78(9):4921-6. PubMed ID: 15078976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.
    Lu L; Tong P; Yu X; Pan C; Zou P; Chen YH; Jiang S
    Biochim Biophys Acta; 2012 Dec; 1818(12):2950-7. PubMed ID: 22867851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein design of an HIV-1 entry inhibitor.
    Root MJ; Kay MS; Kim PS
    Science; 2001 Feb; 291(5505):884-8. PubMed ID: 11229405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.